NIH- vs FDA-Regulated Clinical Trials
Some Statistical Process Differences
When transitioning from an NIH-funded clinical trial to an FDA-regulated clinical trial, biostatisticians face new layers of regulatory oversight and specific procedural requirements. While the statistical principles and modeling techniques may be similar, the rigor of documentation, validation, and adherence to regulations within FDA-regulated trials introduces unique challenges.
[Read More]